Alkem Laboratories Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
|
|
|
|
|
|
|
|
|
Mar '2025 | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 | |
---|---|---|---|---|---|
SOURCES OF FUNDS : | |||||
Equity Share Capital | 23.91 | 23.91 | 23.91 | 23.91 | 23.91 |
Reserves | 12,297.92 | 10,530.70 | 9,325.94 | 8,719.75 | 7,601.84 |
Equity Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Application Money | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Shareholders Funds | 12,321.83 | 10,554.61 | 9,349.85 | 8,743.66 | 7,625.75 |
Secured Loans | 62.88 | 172.02 | 119.31 | 1,010.07 | 327.88 |
Unsecured Loans | 375.83 | 833.19 | 1,062.38 | 1,283.71 | 1,055.63 |
Total Debt | 438.71 | 1,005.21 | 1,181.69 | 2,293.78 | 1,383.51 |
Other Liabilities | 686.88 | 339.19 | 291.48 | 263.91 | 197.35 |
Total Liabilities | 13,447.42 | 11,899.01 | 10,823.02 | 11,301.35 | 9,206.61 |
APPLICATION OF FUNDS : | |||||
Gross Block | 3,083.40 | 3,144.31 | 2,932.25 | 2,826.98 | 2,481.89 |
Less: Accumulated Depreciation | 1,492.06 | 1,362.07 | 1,107.16 | 944.91 | 723.53 |
Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Block | 1,591.34 | 1,782.24 | 1,825.09 | 1,882.07 | 1,758.36 |
Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capital Work in Progress | 76.50 | 90.78 | 228.75 | 232.45 | 323.26 |
Investments | 4,406.78 | 2,828.98 | 3,005.55 | 2,528.61 | 2,152.38 |
Current Assets, Loans & Advances | |||||
Inventories | 1,522.90 | 1,849.56 | 1,724.66 | 1,975.73 | 1,513.26 |
Sundry Debtors | 1,559.84 | 1,753.64 | 1,768.34 | 1,768.22 | 1,556.55 |
Cash and Bank Balance | 1,056.11 | 1,065.85 | 2,163.87 | 2,297.21 | 1,673.36 |
Loans and Advances | 2,559.91 | 3,227.27 | 802.75 | 684.29 | 726.20 |
Total Current Assets | 6,698.76 | 7,896.32 | 6,459.62 | 6,725.45 | 5,469.37 |
Less : Current Liabilities and Provisions | |||||
Current Liabilities | 1,974.11 | 2,028.15 | 1,683.76 | 1,673.80 | 1,367.46 |
Provisions | 174.07 | 110.64 | 224.44 | 194.02 | 198.66 |
Total CL & Provisions | 2,148.18 | 2,138.79 | 1,908.20 | 1,867.82 | 1,566.12 |
Net Current Assets | 4,550.58 | 5,757.53 | 4,551.42 | 4,857.63 | 3,903.25 |
Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax Assets | 1,660.35 | 1,540.21 | 1,292.74 | 1,248.66 | 1,143.51 |
Deferred Tax Liability | 231.21 | 253.55 | 207.82 | 199.92 | 189.08 |
Net Deferred Tax | 1,429.14 | 1,286.66 | 1,084.92 | 1,048.74 | 954.43 |
Other Assets | 1,393.08 | 152.82 | 127.29 | 751.85 | 114.93 |
Total Assets | 13,447.42 | 11,899.01 | 10,823.02 | 11,301.35 | 9,206.61 |
Contingent Liabilities | 1,017.00 | 90.58 | 289.52 | 274.92 | 287.75 |